Last session

GSK plc (GSK) on Decifer Markets

Decifer Markets ranks GSK number 206 of 276 tracked names on durable business quality.

Why it ranks here

  • It keeps about 18 cents of every sales dollar as cash, safer than 80 in 100 companies we measure.
  • It earns about 17% a year on the money put into the business, better than 78 in 100 companies we measure.
  • It makes about 39 cents of gross profit a year on each dollar of assets, more than 70 in 100 companies we measure.
  • Its share count fell about 0.6% over the last year. On not spreading the company over more shares it stands ahead of 54 in 100 companies we measure.
  • Its assets grew about 3% over the last year. On keeping expansion modest it stands ahead of 69 in 100 companies we measure.
  • Its share price rose about 13% over the past year, leaving out the latest month. Stronger than 46 in 100 companies we measure.
  • We could not measure 1 of the seven scores for this company: price. Each counts as 50, the middle, until we can.

The current read

The evidence on GSK lines up on the supportive side: a live market force supports this name through its theme connection. The independent signals we track are telling the same story.

Read the full GSK research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.

Decifer Markets is a media publication. Nothing here is investment advice, a recommendation, or an offer to buy or sell any security.

DisclaimerTermsPrivacyAbout